370 related articles for article (PubMed ID: 15911070)
1. C-type natriuretic peptide and guanylyl cyclase B receptor.
Schulz S
Peptides; 2005 Jun; 26(6):1024-34. PubMed ID: 15911070
[TBL] [Abstract][Full Text] [Related]
2. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A.
Kuhn M
Circ Res; 2003 Oct; 93(8):700-9. PubMed ID: 14563709
[TBL] [Abstract][Full Text] [Related]
3. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice.
Kuhn M
Peptides; 2005 Jun; 26(6):1078-85. PubMed ID: 15911075
[TBL] [Abstract][Full Text] [Related]
4. Molecular physiology of natriuretic peptide signalling.
Kuhn M
Basic Res Cardiol; 2004 Mar; 99(2):76-82. PubMed ID: 14963665
[TBL] [Abstract][Full Text] [Related]
5. Autocrine and paracrine actions of natriuretic peptides in the heart.
D'Souza SP; Davis M; Baxter GF
Pharmacol Ther; 2004 Feb; 101(2):113-29. PubMed ID: 14761702
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptide receptor-C signaling and regulation.
Anand-Srivastava MB
Peptides; 2005 Jun; 26(6):1044-59. PubMed ID: 15911072
[TBL] [Abstract][Full Text] [Related]
7. C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line.
Suda M; Tanaka K; Yasoda A; Komatsu Y; Chusho H; Miura M; Tamura N; Ogawa Y; Nakao K
J Bone Miner Metab; 2002; 20(3):136-41. PubMed ID: 11984695
[TBL] [Abstract][Full Text] [Related]
8. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
[TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system.
Suda M; Tanaka K; Fukushima M; Natsui K; Yasoda A; Komatsu Y; Ogawa Y; Itoh H; Nakao K
Biochem Biophys Res Commun; 1996 Jun; 223(1):1-6. PubMed ID: 8660352
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into the ligand binding domains of membrane bound guanylyl cyclases and natriuretic peptide receptors.
van den Akker F
J Mol Biol; 2001 Aug; 311(5):923-37. PubMed ID: 11556325
[TBL] [Abstract][Full Text] [Related]
11. [The cardiac natriuretic peptides].
Vittorini S; Masini M; Clerico A
Minerva Med; 2006 Feb; 97(1):79-93. PubMed ID: 16565701
[TBL] [Abstract][Full Text] [Related]
12. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
13. Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice.
Steinmetz M; Potthast R; Sabrane K; Kuhn M
Regul Pept; 2004 Jun; 119(1-2):31-7. PubMed ID: 15093694
[TBL] [Abstract][Full Text] [Related]
14. Function and dysfunction of mammalian membrane guanylyl cyclase receptors: lessons from genetic mouse models and implications for human diseases.
Kuhn M
Handb Exp Pharmacol; 2009; (191):47-69. PubMed ID: 19089325
[TBL] [Abstract][Full Text] [Related]
15. Internalization and trafficking of guanylyl cyclase/natriuretic peptide receptor-A.
Pandey KN
Peptides; 2005 Jun; 26(6):985-1000. PubMed ID: 15911067
[TBL] [Abstract][Full Text] [Related]
16. [Hormones and osteoporosis update. Effects of natriuretic peptides on endochondral bone growth].
Yasoda A; Nakao K
Clin Calcium; 2009 Jul; 19(7):1003-8. PubMed ID: 19567998
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
18. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
Kishimoto I; Rossi K; Garbers DL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303
[TBL] [Abstract][Full Text] [Related]
19. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system.
Chen HH; Burnett JC
J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S22-8. PubMed ID: 9883743
[TBL] [Abstract][Full Text] [Related]
20. [Natriuretic peptide system].
Itoh H; Nakao K
Nihon Rinsho; 1997 Aug; 55(8):1923-36. PubMed ID: 9284403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
